Gene Specific Cohorts for Platelet Disorders

Run X1 has a much higher lifetime risk of developing malignancy than ETV6 or ANCA D26. The genetics of the tumors that develop from these three disorders are very distinct giving us information we didn't know before. understanding this kind of information is the beginning of being our two design gene specific monitoring programs for these individuals.